The document is an informed consent form for patients undergoing surgery with DuraSorb® biosynthetic surgical mesh. DuraSorb® is a monofilament mesh made of polydioxanone, an absorbable material used in sutures for over 35 years and FDA‑cleared. The mesh is woven to allow tissue ingrowth, becomes fully integrated within a month, and is completely absorbed by nine months, leaving no permanent foreign material. Its indicated use is reinforcement of soft tissue where weakness exists, providing structural and cosmetic benefits similar to permanent meshes through collagen deposition. The form outlines the primary safety considerations—risks common to implantable meshes such as infection, extrusion, erosion, adhesion, fistula, seroma, and recurrence of the defect. Contraindications include use in the gastrointestinal tract and for cardiovascular reconstruction. Patients are instructed to review the DuraSorb® Instructions for Use and confirm that the surgeon has discussed the information before signing the consent.
Topics
Polydioxanone Composition and Absorption Timeline
Details the material (polydioxanone), its history in absorbable sutures, mesh construction, tissue integration at one month, and complete absorption by nine months.
Indication: Soft‑Tissue Reinforcement
Specifies that DuraSorb® is intended to reinforce weak soft tissue, offering structural and cosmetic benefits comparable to longer‑lasting meshes.
Clinical Benefits and Tissue Integration
Explains how the mesh’s woven openings allow tissue ingrowth, leading to collagen formation and eventual disappearance of foreign material after one year.
Safety Risks Common to Implantable Meshes
Lists the primary risks patients may experience: infection, extrusion, erosion, adhesion, fistula formation, seroma, and recurrence of the defect.
Contraindications and Usage Limitations
Identifies prohibited applications: placement in the gastrointestinal tract and reconstruction of cardiovascular defects.
Patient Consent Process
Describes the requirement for surgeon discussion, patient acknowledgment, signature, and date to confirm understanding and willingness to proceed.